Genetic and pharmacogenomic landscape of editing in cancers

GPEdit systematically investigated the impact of genetic variants and pharmacogenomics landscape of RNA editing event across multiple cancer types.

Please cite:  Ruan H#, Li Q, Liu Y, Liu Y, Lussier C, Diao L, Han L#. GPEdit: the genetic and pharmacogenomic landscape of A-to-I RNA editing in cancers. Nucleic Acids Research. 2021. gkab810. PMID: 34534336

# Cancer Patients

# Editing QTLs

# Compounds

Query by modules
img1_edQTL
edQTL
img2_surv
Survival-edQTL
img3_GWAS
GWAS-edQTL
img4_drug
Drug Response


Query by cancer types
ACC_image
ACC
n=79
BLCA_image
BLCA
n=408
BRCA_image
BRCA
n=1092
CESC_image
CESC
n=304
CHOL_image
CHOL
n=37
COAD_image
COAD
n=456
DLBC_image
DLBC
n=48
ESCA_image
ESCA
n=164
GBM_image
GBM
n=149
HNSC_image
HNSC
n=501
KICH_image
KICH
n=66
KIRC_image
KIRC
n=530
KIRP_image
KIRP
n=289
LAML_image
LAML
n=151
LGG_image
LGG
n=455
LIHC_image
LIHC
n=371
LUAD_image
LUAD
n=515
LUSC_image
LUSC
n=501
MESO_image
MESO
n=86
OV_image
OV
n=389
PAAD_image
PAAD
n=177
PCPG_image
PCPG
n=179
PRAD_image
PRAD
n=496
READ_image
READ
n=167
SARC_image
SARC
n=259
SKCM_image
SKCM
n=468
STAD_image
STAD
n=380
TGCT_image
TGCT
n=150
THCA_image
THCA
n=502
THYM_image
THYM
n=119
UCEC_image
UCEC
n=555
UCS_image
UCS
n=56
UVM_image
UVM
n=80